Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SI-BONE, Inc. Director's Dealing 2018

Oct 16, 2018

32647_dirs_2018-10-16_c079ba8a-7538-4186-b8ee-326ad966d84e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2018-10-16

Reporting Person: Montreux Equity Partners IV, L.P. (10% Owner)
Reporting Person: Montreux IV Associates, LLC (10% Owner)
Reporting Person: Montreux IV Associates IV, LLC (10% Owner)
Reporting Person: Montreux Equity Management IV, LLC (10% Owner)
Reporting Person: TURNER DANIEL K III (10% Owner)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series 5 Preferred Stock $ Common Stock (1096816) Indirect
Series 5 Preferred Stock $ Common Stock (78564) Indirect
Series 6 Preferred Stock $ Common Stock (563926) Indirect
Series 6 Preferred Stock $ Common Stock (48950) Indirect
Series 7 Preferred Stock $ Common Stock (27409) Indirect
Series 7 Preferred Stock $ Common Stock (171929) Indirect
Warrant (right to buy) $9.10 Series 5 Preferred Stock (15496) Indirect

Footnotes

F1: The Issuer's Series 4 Preferred Stock, Series 5 Preferred Stock and Series 7 Preferred Stock will automatically convert into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.

F2: Montreux Equity Management IV, L.L.C. ("MEM IV LLC") is the general partner of each of Montreux Equity Partners IV, L.P., Montreux IV Associates, L.L.C and Montreux IV Associates IV, L.L.C. Daniel K. Turner III is the managing director of MEM IV LLC and may be deemed to have voting and investment power over the shares held by each of these entities. Mr. Turner disclaims beneficial ownership of such shares, except to the extent of his proportionate pecuniary interest, if any.

F3: The Issuer's Series 6 Preferred Stock will automatically convert into approximately 1.05878 shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.

F4: Shares subject to the warrant are immediately exercisable. The warrant will expire in connection with the closing of the Issuer's initial public offering.